All Stories

  1. Associations between Melatonin, Neuroinflammation, and Brain Alterations in Depression
  2. Gut Microbiota and Bipolar Disorder: An Overview on a Novel Biomarker for Diagnosis and Treatment
  3. Crosstalk between Depression and Dementia with Resting-State fMRI Studies and Its Relationship with Cognitive Functioning
  4. Neuroinflammation-Associated Alterations of the Brain as Potential Neural Biomarkers in Anxiety Disorders
  5. Immunomodulatory Effects of Antipsychotic Drugs in Whole Blood Cell Cultures from Healthy Subjects
  6. Rethinking Depression
  7. Treatment Resistance in Psychiatry
  8. Meet Our Editor-in-Chief
  9. Neuroinflammation and the Immune-Kynurenine Pathway in Anxiety Disorders
  10. The Microbiota-Gut-Brain Axis in Neuropsychiatric Disorders: Pathophysiological Mechanisms and Novel Treatments
  11. The role of neuroinflammation and neurovascular dysfunction in major depressive disorder
  12. Evidence for additionally increased apoptosis in the peripheral blood mononuclear cells of major depressive patients with a high risk for suicide
  13. Understanding Depression
  14. Understanding Depression
  15. An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms
  16. Gender Differences in Depression
  17. Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome
  18. The influence of stress on neuroinflammation and alterations in brain structure and function in major depressive disorder
  19. Common and distinct brain networks underlying panic and social anxiety disorders
  20. A Novel Bio-Psychosocial-Behavioral Treatment Model in Schizophrenia
  21. Influence of FKBP5 polymorphism and DNA methylation on structural changes of the brain in major depressive disorder
  22. Increased levels of 5HT2A receptor mRNA expression in peripheral blood mononuclear cells of patients with major depression: correlations with severity and duration of illness
  23. Neuroprotection in Schizophrenia and Its Therapeutic Implications
  24. Plasticity-augmented psychotherapy for refractory depressive and anxiety disorders
  25. Can we cope with treatment refractoriness in psychiatric disorders?
  26. Clinical and neurobiological factors in the management of treatment refractory attention-deficit hyperactivity disorder
  27. Stress, the Autonomic Nervous System, and the Immune-kynurenine Pathway in the Etiology of Depression
  28. The G allele in IL-10-1082 G/A may have a role in lowering the susceptibility to panic disorder in female patients
  29. Molecular Neurobiology and Promising New Treatment in Depression
  30. Brain-derived neurotrophic factor promoter methylation and cortical thickness in recurrent major depressive disorder
  31. Neurobiological Correlates on Psychotherapy in Depression
  32. Biochemical Markers
  33. Molecular neurobiology of major depressive disorder
  34. Decreased Plasma BDNF Levels of Patients with Somatization Disorder
  35. Neuroinflammation and cytokine abnormality in major depression: Cause or consequence in that illness?
  36. The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression
  37. Cognitive Impairment in Depression
  38. Alterations in plasma vascular endothelial growth factor levels in patients with schizophrenia before and after treatment
  39. Plasma glial cell line-derived neurotrophic factor in patients with major depressive disorder: a preliminary study
  40. Major Depressive Disorder - Cognitive and Neurobiological Mechanisms
  41. Different Mechanisms Between Melancholic and Atypical Depression
  42. The Effects of Psychotherapy on Brain Function — Major Depressive Disorder
  43. Increased levels of plasma glial-derived neurotrophic factor in children with attention deficit hyperactivity disorder
  44. Optimal Treatment for Depression during Pregnancy and Lactation
  45. The role of immunity and neuroinflammation in genetic predisposition and pathogenesis of Alzheimer's disease
  46. Evidence for Association between the Brain-Derived Neurotrophic Factor Gene and Panic Disorder: A Novel Haplotype Analysis
  47. Alteration of Brain-Derived Neurotrophic Factor Levels in Panic Disorder
  48. Association between norepinephrine transporter gene (SLC6A2) polymorphisms and suicide in patients with major depressive disorder
  49. There is no association between the serotonin receptor gene and bipolar I disorder in the Korean population
  50. The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia
  51. Network beyond IDO in psychiatric disorders: Revisiting neurodegeneration hypothesis
  52. High insulin-like growth factor-1 in patients with bipolar I disorder: A trait marker?
  53. TNF-alpha −308G>A polymorphism is associated with suicide attempts in major depressive disorder
  54. Decreased gray matter volume of the medial orbitofrontal cortex in panic disorder with agoraphobia: A preliminary study
  55. Biological Markers and Genetic Factors of Major Depressive Disorder
  56. Distinguishing Quantitative Electroencephalogram Findings between Adjustment Disorder and Major Depressive Disorder
  57. Plasma Levels of IL-23 and IL-17 before and after Antidepressant Treatment in Patients with Major Depressive Disorder
  58. Anti-Intrusion Effect of Lorazepam: An Experimental Study
  59. Temperament and Character of Young Male Conscripts With Adjustment Disorder
  60. Bright light therapy as an adjunctive treatment with risperidone in patients with delirium: a randomized, open, parallel group study
  61. Characteristics of Type D personality in Korean adolescents
  62. Biological Prediction of Suicidal Behavior in Patients with Major Depressive Disorder
  63. Increased plasma VEGF levels in major depressive or manic episodes in patients with mood disorders
  64. State Effect of Traumatic Experience on Personality Structure
  65. A Case of Blonanserin-Induced Mania in Schizophrenia
  66. Adjunctive treatment of bimodal repetitive transcranial magnetic stimulation (rTMS) in pharmacologically non-responsive patients with schizophrenia: A preliminary study
  67. The Mediating Effect of Psychosocial Factors on Suicidal Probability among Adolescents
  68. Role of cytokines in atypical depression
  69. Paliperidone in the treatment of delirium: results of a prospective open-label pilot trial
  70. The T allele of the interferon-gamma +874A/T polymorphism is associated with bipolar disorder
  71. The impact of glycogen synthase kinase 3β gene on psychotic mania in bipolar disorder patients
  72. Suicide and suicidal behavior
  73. Potential peripheral biological predictors of suicidal behavior in major depressive disorder
  74. Effect of Serotonin-Related Gene Polymorphisms on Pathogenesis and Treatment Response in Korean Schizophrenic Patients
  75. Assessment of the Type D Personality Construct in the Korean Population: A Validation Study of the Korean DS14
  76. Gender Effect of Catechol-O-Methyltransferase Val158Met Polymorphism on Suicidal Behavior
  77. No Evidence for an Association between Dopamine D2 Receptor Polymorphisms and Tardive Dyskinesia in Korean Schizophrenia Patients
  78. Borna Disease Virus Antibody and RNA from Peripheral Blood Mononuclear Cells of Race Horses and Jockeys in Korea
  79. Psychotropic Drugs on In Vitro Brain-Derived Neurotrophic Factor Production in Whole Blood Cell Cultures From Healthy Subjects
  80. BDNF mRNA expression of peripheral blood mononuclear cells was decreased in depressive patients who had or had not recently attempted suicide
  81. Effect of TGF-β1 polymorphism on the susceptibility to schizophrenia and treatment response to atypical antipsychotic agent
  82. A case-control association study of serotonin 1A receptor gene and tryptophan hydroxylase 2 gene in attention deficit hyperactivity disorder
  83. Efficacy and Tolerability of Blonanserin in the Patients With Schizophrenia
  84. Association study between antipsychotic-induced restless legs syndrome and polymorphisms of monoamine oxidase genes in schizophrenia
  85. Transforming growth factor-β1 and major depressive disorder with and without attempted suicide: Preliminary study
  86. BDNF MRNA EXPRESSION OF PERIPHERAL BLOOD MONONUCLEAR CELLS WAS DECREASED IN PATIENTS WITH SCHIZOPHRENIA
  87. Association between glycogen synthase kinase-3β gene polymorphisms and major depression and suicidal behavior in a Korean population
  88. Catechol-O-methyltransferase Val158Met polymorphism affects therapeutic response to mood stabilizer in symptomatic manic patients
  89. The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment
  90. Association between Serotonin-Related Polymorphisms in 5HT2A, TPH1, TPH2 Genes and Bipolar Disorder in Korean Population
  91. Association Study between 5-HT1A Receptor Gene C(-1019)G Polymorphism and Panic Disorder in a Korean Population
  92. Reduced platelet BDNF level in patients with major depression
  93. Cytokine Changes and Tryptophan Metabolites in Medication-Naïve and Medication-Free Schizophrenic Patients
  94. Increased Plasma Brain-Derived Neurotropic Factor, Not Nerve Growth Factor-Beta, in Schizophrenia Patients with Better Response to Risperidone Treatment
  95. No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients
  96. Failure to Detect Borna Disease Virus Antibody and RNA from Peripheral Blood Mononuclear Cells of Psychiatric Patients
  97. Increased Transforming Growth Factor-beta1 in Alcohol Dependence
  98. Manganese superoxide dismutase gene Ala–9Val polymorphism might be related to the severity of abnormal involuntary movements in Korean schizophrenic patients
  99. The association between serotonin-related gene polymorphisms and panic disorder
  100. A single administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin that produces reduced food and water intake induces long-lasting expression of corticotropin-releasing factor, arginine vasopressin, and proopiomelanocortin in rat brain
  101. Reduced plasma nitric oxide metabolites before and after antipsychotic treatment in patients with schizophrenia compared to controls
  102. No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients
  103. Association between serotonin-related gene polymorphisms and suicidal behavior in depressive patients
  104. Prediction of postpartum depression by sociodemographic, obstetric and psychological factors: A prospective study
  105. Differences in cytokines between non-suicidal patients and suicidal patients in major depression
  106. Association Study between Antipsychotics- Induced Restless Legs Syndrome and Polymorphisms of Dopamine D1, D2, D3, and D4 Receptor Genes in Schizophrenia
  107. Possible association between the −2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain
  108. Gender Differences in Suicidal Behavior in Korea
  109. Plasma Brain-Derived Neurotrophic Factor as a Peripheral Marker for the Action Mechanism of Antidepressants
  110. Cognitive Factors for Predicting Treatment Response in Schizophrenic Patients: One-Year Follow-Up Study
  111. Possible association between G-protein β3 subunit C825T polymorphism and antipsychotic-induced restless legs syndrome in schizophrenia
  112. Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder
  113. Monocytic, Th1 and Th2 Cytokine Alterations in the Pathophysiology of Schizophrenia
  114. Decreased Plasma Brain-Derived Neurotrophic Factor Levels in Patients With Alcohol Dependence
  115. Increased plasma brain-derived neurotrophic factor levels in chronic smokers following unaided smoking cessation
  116. Decreased plasma BDNF level in depressive patients
  117. No Association between Dopamine D4 Receptor Gene –521 C/T Polymorphism and Tardive Dyskinesia in Schizophrenia
  118. Characteristics and clinical correlates of restless legs syndrome in schizophrenia
  119. Cytokine imbalance in the pathophysiology of major depressive disorder
  120. The five-factor gambling motivation model
  121. Gambling Motives Scale
  122. Increased plasma nitric oxide level associated with suicide attempt in depressive patients
  123. The role of IL-12 and TGF-β1 in the pathophysiology of major depressive disorder
  124. No borna disease virus-specific RNA detected in blood of race horses and jockeys
  125. Possible Role of Nerve Growth Factor in the Pathogenesis of Alcohol Dependence
  126. The relationship between prolactin response and clinical efficacy of risperidone in acute psychotic inpatients
  127. Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: A pilot study
  128. Increased Plasma Nitric Oxide Metabolites in Suicide Attempters
  129. High concentrations of plasma brain-derived neurotrophic factor in methamphetamine users
  130. G-Protein β3 Subunit C825T Polymorphism Tends to Be Associated with Seasonal Variation in Young Male College Students
  131. Latency of auditory P300 correlates with self-control as measured by the Sixteen Personality Factor Questionnaire
  132. The Role of Cytokine Network in the Pathophysiology of Schizophrenia
  133. Antipsychotics and dopamine transporter gene polymorphisms in delirium patients
  134. The role of the immune system in the pathophysiology of schizophrenia
  135. Th1, Th2 and Th3 cytokine alteration in schizophrenia
  136. A Double-Blind Trial of Risperidone and Haloperidol for the Treatment of Delirium
  137. Neurocognitive function and quality of life in relation to hematocrit levels in chronic hemodialysis patients
  138. Auditory Event-Related Potentials and Psychological Changes during Sleep Deprivation
  139. Abnormal speech perception in schizophrenia with auditory hallucinations
  140. The Effects of Antidepressant Treatment on Serum Cytokines and Nutritional Status in Hemodialysis Patients
  141. Effects of alcohol hangover on cytokine production in healthy subjects
  142. Borna disease virus and deficit schizophrenia
  143. Serum lipid levels and suicide attempts
  144. D2 and D4 dopamine receptor gene polymorphisms and personality traits in a young Korean population
  145. The role of the cytokine network in psychological stress
  146. Neurobiology of Depression
  147. Low serum cholesterol is correlated to suicidality in a Korean sample
  148. Psychiatric Symptoms Reported by International Peacekeeping Personnel in the Western Sahara Desert
  149. Effect of Risperidone on Serum Cytokines
  150. Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics
  151. Risperidone and Associated Amenorrhea
  152. Failure to demonstrate Borna disease virus genome in peripheral blood mononuclear cells from psychiatric patients in Korea
  153. Decreased Interleukin-2 Production in Korean Schizophrenic Patients